Publications: Dr Jack Thompson

Magavern EF, Megase M, Thompson J, Marengo G, Jacobsen J, Smedley D, Caulfield MJ ( 2025 ) . Pharmacogenetics and adverse drug reports: Insights from a United Kingdom national pharmacovigilance database . PLOS Medicine vol. 22 , ( 3 )

Hunt A, Ditri D, Chadha A, Keogh G, Thompson J, Loughborough W, McNeish I, Krell J et al. ( 2024 ) . Homologous recombination deficiency testing in patients with high grade ovarian cancer: factors influencing test success . Future Oncology vol. 21 , ( 3 ) 341 - 347 .

Thompson JT, Wood DM, Dargan PI ( 2024 ) . Review of the fluoropyrimidine antidote uridine triacetate . British Journal of Clinical Pharmacology vol. 91 , ( 3 ) 615 - 627 .

Ditri D, Hunt A, Chadha A, Keogh G, Thompson J, Loughborough W, McNeish I, Krell J et al. ( 2024 ) . OC04.06: A comparison of the homologous recombination deficiency test success rate using samples from ultrasound‐guided biopsies and those obtained during laparotomies in advanced ovarian cancer . Ultrasound in Obstetrics and Gynecology vol. 64 , ( S1 ) 11 - 12 .

McCarley SC, Murphy DA, Thompson J, Shovlin CL ( 2023 ) . Pharmacogenomic Considerations for Anticoagulant Prescription in Patients with Hereditary Haemorrhagic Telangiectasia . Journal of Clinical Medicine vol. 12 , ( 24 )